HUP9903911A2 - Use of inhibitors of pkc for the preparation of pharmaceutical compositions treating central nervous system diseases associated with hiv infection
- Google Patents
Use of inhibitors of pkc for the preparation of pharmaceutical compositions treating central nervous system diseases associated with hiv infection
Info
Publication number
HUP9903911A2
HUP9903911A2HU9903911AHUP9903911AHUP9903911A2HU P9903911 A2HUP9903911 A2HU P9903911A2HU 9903911 AHU9903911 AHU 9903911AHU P9903911 AHUP9903911 AHU P9903911AHU P9903911 A2HUP9903911 A2HU P9903911A2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co.,filedCriticalEli Lilly And Co.,
Priority claimed from PCT/US1997/015583external-prioritypatent/WO1998008510A1/en
Publication of HUP9903911A2publicationCriticalpatent/HUP9903911A2/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Treatment of central nervous system disease associated with human immunodeficiency virus (HIV) comprises administration of an inhibitor of the ~b isozyme of protein kinase C (PKC).
HU9903911A1996-08-301997-08-28Use of inhibitors of pkc for the preparation of pharmaceutical compositions treating central nervous system diseases associated with hiv infection
HUP9903911A2
(en)
The use of saredutan and its pharmaceutically acceptable salts for the preparation of medicinal products useful in the treatment or prevention of all mental disorders, adaptation disorders and various anxiety-depression disorders.